In CF patients with PTC mutations in the CFTR gene, treatment with PTC124 slightly increased chloride channel activity, resulting in an improvement of clinical parameters (Kerem et al., 2008); however, not all patients responded positively to the drug. This evidence concerns the gene CFTR and cystic fibrosis.